Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8529 |
High Similarity |
NPD8434 |
Phase 2 |
0.8344 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.8323 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7963 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7949 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7919 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7919 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7879 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7866 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7848 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD3749 |
Approved |
0.784 |
Intermediate Similarity |
NPD920 |
Approved |
0.7799 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.774 |
Intermediate Similarity |
NPD6785 |
Approved |
0.774 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7725 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7665 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.761 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7607 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7593 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7572 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7529 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD2800 |
Approved |
0.75 |
Intermediate Similarity |
NPD2534 |
Approved |
0.75 |
Intermediate Similarity |
NPD2532 |
Approved |
0.75 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7457 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7453 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7442 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7439 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7438 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7407 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7399 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD919 |
Approved |
0.7375 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7337 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7288 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7256 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7256 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7238 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7238 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7225 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7216 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7215 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7209 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7202 |
Intermediate Similarity |
NPD5403 |
Approved |
0.72 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7193 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7186 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7168 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7158 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7125 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7125 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD37 |
Approved |
0.7089 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7072 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7069 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7069 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7069 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7062 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7052 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7032 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7006 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.6995 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD6280 |
Approved |
0.6994 |
Remote Similarity |
NPD6279 |
Approved |
0.697 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.697 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.697 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD5710 |
Approved |
0.6966 |
Remote Similarity |
NPD5711 |
Approved |
0.6961 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6961 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6952 |
Remote Similarity |
NPD4287 |
Approved |
0.6951 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6951 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD17 |
Approved |
0.6935 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6923 |
Remote Similarity |
NPD1511 |
Approved |
0.6923 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD9717 |
Approved |
0.6914 |
Remote Similarity |
NPD5616 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD2296 |
Approved |
0.6906 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6902 |
Remote Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD1203 |
Approved |
0.6899 |
Remote Similarity |
NPD1470 |
Approved |
0.6899 |
Remote Similarity |
NPD2797 |
Approved |
0.6893 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6891 |
Remote Similarity |
NPD6779 |
Approved |
0.6891 |
Remote Similarity |
NPD6781 |
Approved |
0.6891 |
Remote Similarity |
NPD6782 |
Approved |
0.6891 |
Remote Similarity |
NPD6780 |
Approved |
0.6891 |
Remote Similarity |
NPD6778 |
Approved |
0.6891 |
Remote Similarity |
NPD6776 |
Approved |
0.6891 |
Remote Similarity |
NPD6777 |
Approved |
0.6885 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6871 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6871 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6868 |
Remote Similarity |
NPD7054 |
Approved |
0.6862 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6842 |
Remote Similarity |
NPD1512 |
Approved |
0.6839 |
Remote Similarity |
NPD1778 |
Approved |
0.6839 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6839 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD1876 |
Approved |
0.6833 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6831 |
Remote Similarity |
NPD7472 |
Approved |
0.6828 |
Remote Similarity |
NPD8407 |
Phase 2 |
0.681 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6796 |
Remote Similarity |
NPD2403 |
Approved |
0.6793 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.679 |
Remote Similarity |
NPD411 |
Approved |
0.679 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6788 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6786 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6786 |
Remote Similarity |
NPD7698 |
Approved |
0.6786 |
Remote Similarity |
NPD7697 |
Approved |
0.678 |
Remote Similarity |
NPD7057 |
Phase 3 |
0.678 |
Remote Similarity |
NPD7058 |
Phase 2 |
0.6768 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6768 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6768 |
Remote Similarity |
NPD447 |
Suspended |
0.6766 |
Remote Similarity |
NPD5762 |
Approved |
0.6766 |
Remote Similarity |
NPD5763 |
Approved |
0.6761 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6757 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6757 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6751 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6751 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.675 |
Remote Similarity |
NPD7874 |
Approved |
0.675 |
Remote Similarity |
NPD5647 |
Approved |
0.675 |
Remote Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.675 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6746 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6743
|
Remote Similarity |
NPD5889 |
Approved |